Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Super Smart, a division of PharmaDrug (BUZZ), has launched a Slim Winkel branded online retail platform in the United States that will focus on the sale of functional mushrooms
  • The Slim Winkel e-commerce site will include informative blogs and educational tips
  • The European Slim Winkel online store will be launched in the next two weeks, and the bricks and mortar strategy will resume once COVID-19 lockdowns have subsided
  • PharmaDrug (BUZZ) is a specialty pharmaceutical company
  • Its subsidiary Super Smart is a Dutch company building a modern adult-use psychedelic retail business with an educational focus.
  • PharmaDrug Inc. (BUZZ) is steady, trading for $0.085 per share

Super Smart, a division of PharmaDrug (BUZZ), has launched a Slim Winkel branded online retail platform in the United States.

The specialty online shop features a carefully curated selection of functional mushrooms, a first for the functional mushrooms category.

Visitors to the Slim Winkel e-commerce site will be treated to informative blogs and educational tips that will allow them to easily integrate the mushrooms into their lifestyle.

Harry Resin, president of Super Smart, commented on the launch.

“This store is the culmination of over two decades of personal experience with plant medicine, including superfoods and functional mushrooms, and I couldn’t be more excited to launch,” he remarked.

Super Smart made the strategic decision to establish an online presence while lockdowns related to the COVID-19 pandemic remained in effect, even in the U.S. where lockdowns are now being lifted.

The platform in the U.S. will also enable Super Smart to capitalize on an already established distribution model should psychedelics legalize in the U.S.

The European Slim Winkel online store will be launched in the next two weeks, and the bricks-and-mortar strategy will resume once management is confident the lockdowns have subsided.

Super Smart has located several building locations in Amsterdam its major flagship store. The buildout of that store is a core focus, and management plans to sign a lease and commence building as soon as the country opens up on a seemingly permanent basis.

PharmaDrug (BUZZ) is a specialty pharmaceutical company focused on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs.

Its subsidiary Super Smart is a Dutch company building a modern adult-use psychedelic retail business with an educational focus.

PharmaDrug Inc. (BUZZ) is steady, trading for $0.085 per share as of 1:14 pm ET.

More From The Market Herald

" Optimi Health (CSE:OPTI) signs psilocybin supply agreement with Halucenex Life Sciences

Optimi Health (OPTI) has announced a supply agreement with Halucenex Life Sciences Inc., a wholly-owned subsidiary of Creso Pharma of Australia.

" Revive (CSE:RVV) gets FDA OK for Bucillamine trials to treat COVID-19

Revive Therapeutics (RVV), a cannabis and psychedelic healthcare company has received feedback from the U.S. FDA to help advance Bucillamine.

" Clearmind Medicine (CSE:MIND) and SciSparc report positive results for Psychedelic Combination Treatment

Clearmind Medicine (MND) has released favourable safety profile results from its joint pre-clinical trial with SciSparc Ltd. (NASDAQ: SPRC).

" Optimi Health (CSE:OPTI) acquires catalog of psychedelic and functional mushroom genetics

Optimi Health (OPTI) has acquired a catalog of psilocybin and functional mushroom strains.